Plant-derived anticancer agents: A green anticancer approach

Asian Pacific Journal of Tropical Biomedicine

Volumn 7, Issue 12, 2017, Pages 1129-1150

  Iqbal, Javed ^a   Abbasi, Banzeer Ahsan ^a   Mahmood, Tariq ^a   Kanwal, Sobia ^b   Ali, Barkat ^a   Shah, Sayed Afzal ^a   Khalil, Ali Talha ^c,d,e  

^a QUAID I AZAM UNIVERSITY   (Pakistan)

^b UNIVERSITY OF GUJRAT   (Pakistan)

^c Qarshi University   (Pakistan)

^d UNESCO UNISA Africa Chair in Nanoscience and Nanotechnology   (South Africa)

^e IThemba LABS   (South Africa)

Author keywords

Analogs; Cancer; Limitations of anticancer drugs; Phytochemicals

Indexed keywords

ALPHA TOCOTRIENOL; APIGENIN; BERBERINE; BETA ELEMENE; CAMPTOTHECIN; CAPSAICIN; CHALCONE; COLCHICINE; COMBRETASTATIN; CROCETIN; CURCUMIN; CYANIDIN GLYCOSIDE; DOCETAXEL; ELLIPTICINE; EPIGALLOCATECHIN GALLATE; FISETIN; FLAVONOID; GINGEROL; GLYCOSIDE; LAROTAXEL; LYCOPENE; MILATAXEL; ORTATAXEL; PACLITAXEL; RESVERATROL; TESETAXEL; TOCOPHEROL; TRITERPENOID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCA ALKALOID;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; BERBERIS; BERBERIS AQUIFOLIUM; BERBERIS VULGARIS; CAMPTOTHECA; CAMPTOTHECA ACUMINATA; CATHARANTHUS ROSEUS; CEPHALOTAXUS HARRINGTONIA; COLCHICUM; COLCHICUM AUTUMNALE; COMBRETUM; COMBRETUM CAFFRUM; CORYLUS AVELLANA; CROCUS SATIVUS; DIETARY FIBER; DRUG DEGRADATION; DRUG EFFICACY; DRUG ISOLATION; GLORIOSA SUPERBA; GREEN CHEMISTRY; MUSHROOM; NONHUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL; REVIEW; RHIZOMA COPTIDIS; RHIZOME; TAXUS; TAXUS BACCATA; TAXUS CANADENSIS; TINOSPORA CORDIFOLIA;

EID: 85035141220     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apjtb.2017.10.016     Document Type: Review

References (273)

1. He, L., Gu, J., Lim, L.Y., Yuan, Z.X., Mo, J., Nanomedicine-mediated therapies to target breast cancer stem cells. Front Pharmacol, 7, 2016, 313.
2. Qin, W., Huang, G., Chen, Z., Zhang, Y., Nanomaterials in targeting cancer stem cells for cancer therapy. Front Pharmacol, 8, 2017, 1.
3. Zhang, L.Q., Lv, R.W., Qu, X.D., Chen, X.J., Lu, H.S., Wang, Y., et al. Aloesin suppresses cell growth and metastasis in ovarian cancer SKOV3 cells through the inhibition of the MAPK signaling pathway. Anal Cell Pathol 2017 (2017), 1–6.
4. American Cancer Society, Cancer facts & figures 2016. 2016, American Cancer Society, Atlanta, GA.
5. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2016. CA Cancer J Clin 66:1 (2016), 7–30.
6. Siegel, R.L., Miller, K.D., Fedewa, S.A., Ahnen, D.J., Meester, R.G., Barzi, A., et al. Colorectal cancer statistics, 2017. CA Cancer J Clin 67:3 (2017), 177–193.
7. Krishnamurthi, K., 17-screening of natural products for anticancer and antidiabetic properties. Cancer, 3, 2007, 4.
8. Horn, L., Pao, W., Johnson, D.H., Neoplasms of the lung. Chapter89. Longo, D.L., Kasper, D.L., Jamson, J.L., Fauci, A.S., Hauser, S.L., Loscalzo, J., (eds.) Harrisons principles of internal medicine, 18th ed., 2012, MacGraw-Hill, New York, NY.
9. Zhou, Z., Tang, M., Liu, Y., Zhang, Z., Lu, R., Lu, J., Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line. Anti Cancer Drugs 28:4 (2017), 446–456.
10. Kharb, M., Jat, R.K., Gupta, R., A review on medicinal plants used as a source of anticancer agents. Int J Drug Res Technol 2 (2012), 177–183.
11. Dixit, S., Ali, H., Anticancer activity of medicinal plant extract-a review. J Chem Chem Sci 1 (2010), 79–85.
12. Parkin, D., Bray, M.F., Ferlay, J., Pisani, P., Global cancer statistics. CA Cancer J Clin 55 (2015), 74–108.
13. Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (2015), E359–E386.
14. Faria, S.S., Morris, C.F.M., Silva, A.R., Fonseca, M.P., Forget, P., Castro, M.S., et al. A timely shift from shotgun to targeted proteomics and how it can be groundbreaking for cancer research. Front Oncol, 7, 2017, 13.
15. Thakore, P., Mani, R.K., Kavitha, S.J., A brief review of plants having anti-cancer property. Int J Pharm Res Dev 3 (2012), 129–136.
16. Cragg, G.M., Newman, D.J., Yang, S.S., Natural product extracts of plant and marine origin having antileukemia potential. The NCI experience. J Nat Prod 69 (2016), 488–498.
17. Khan, H., Medicinal plants in light of history: recognized therapeutic modality. J Evid Based Complement Altern Med 19 (2014), 216–219.
18. Weaver, B.A., How taxol/paclitaxel kills cancer cells. Mol Biol Cell 25:18 (2014), 2677–2681.
19. Singh, S., Bhupender, S., Kanwar, S.S., Kumar, A., Lead phytochemicals for anticancer drug development. Front Plant Sci, 7, 2016, 1667.
20. Vinogradov, S., Wei, X., Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomedicine 7 (2012), 597–615.
21. Patra, C.R., Mukherjee, S., Kotcherlakota, R., Biosynthesized silver nanoparticles: a step forward for cancer theranostics?. Nanomedicine 9 (2014), 1445–1448.
22. Mukherjee, S., Patra, C.R., Therapeutic application of anti-angiogenic nanomaterials in cancers. Nanoscale 8 (2016), 12444–12470.
23. Caruso, M., Colombo, A.L., Fedeli, L., Pavesi, A., Quaroni, S., Saracchi, M., et al. Isolation of endophytic fungi and actinomycetes taxane producers. Ann Microbiol 50 (2000), 3–14.
24. Aung, T.N., Qu, Z., Kortschak, R.D., Adelson, D.L., Understanding the effectiveness of natural compound mixtures in cancer through their molecular mode of action. Int J Mol Sci, 18(3), 2017, 656.
25. Tariq, A., Sadia, S., Pan, K., Ullah, I., Mussarat, S., Sun, F., et al. A systematic review on ethnomedicines of anti-cancer plants. Phytother Res 31 (2017), 202–264.
26. Ayoob, I., Hazari, Y.M., Lone, S.H., Khuroo, M.A., Fazili, K.M., Bhat, K.A., et al. Phytochemical and cytotoxic evaluation of peganum harmala: structure activity relationship studies of harmine. Chem Sel 2:10 (2017), 2965–2968.
27. Ooko, E., Kadioglu, O., Greten, H.J., Efferth, T., Pharmacogenomic characterization and isobologram analysis of the combination of ascorbic acid and curcumin-two main metabolites of Curcuma longa-in cancer cells. Front Pharmacol, 2017, 10.3389/fphar.2017.00038.
28. Bhandari, J., Muhammad, B., Thapa, P., Shrestha, B.G., Study of phytochemical, anti-microbial, anti-oxidant, and anti-cancer properties of Allium wallichii. BMC Compl Altern Med, 17(1), 2017, 102.
29. Efferth, T., From ancient herb to versatile, modern drug: Artemisia annua and artemisinin for cancer therapy. Semin Canc Biol, 2017, 10.1016/j.semcancer.2017.02.009.
30. Kumari, M., Pattnaik, B., Rajan, S.Y., Shrikant, S., Surendra, S.U., EGCG-A Promis anti-cancer Phytochem 3:2 (2017), 8–10.
31. Preethi, R., Padma, P.R., Biosynthesis and bioactivity of silver nanobioconjugates from grape (vitis vinifera) seeds and its active component resveratrol. Int J Pharma Sci Res, 7(10), 2016, 4253.
32. Xiong, M., Wang, L., Yu, H.L., Han, H., Mao, D., Chen, J., et al. Ginkgetin exerts growth inhibitory and apoptotic effects on osteosarcoma cells through inhibition of STAT3 and activation of caspase-3/9. Oncolo Rep 35:2 (2016), 1034–1040.
33. Wu, F., Zhou, L., Jin, W., Yang, W., Wang, Y., Yan, B., et al. Anti-proliferative and apoptosis-inducing effect of theabrownin against non-small cell lung adenocarcinoma A549 cells. Front Pharmacol, 7, 2016, 465.
34. Beg, M.A., Teotia, U.V., Farooq, S., In vitro antibacterial and anticancer activity of Ziziphus. J Med Plants 4:5 (2016), 230–233.
35. Al Sinani, S.S., Eltayeb, E.A., Coomber, B.L., Adham, S.A., Solamargine triggers cellular necrosis selectively in different types of human melanoma cancer cells through extrinsic lysosomal mitochondrial death pathway. Cancer Cell Inte, 16(1), 2016, 11.
36. Mehdad, A., Brumana, G., Souza, A.A., Barbosa, J.A., Ventura, M.M., de Freitas, S.M., et al. A Bowman-Birk inhibitor induces apoptosis in human breast adenocarcinoma through mitochondrial impairment and oxidative damage following proteasome 20S inhibition. Cell Death Dis, 2, 2016, 15067.
37. Jaradat, N.A., Al-Ramahi, R., Zaid, A.N., Ayesh, O.I., Eid, A.M., Ethnopharmacological survey of herbal remedies used for treatment of various types of cancer and their methods of preparations in the West Bank-Palestine. BMC Comp Altern Med, 16(1), 2016, 93.
38. Zhang, Y.Y., Huang, C.T., Liu, S.M., Wang, B., Guo, J., Bai, J.Q., et al. Licochalcone A exerts antitumor activity in bladder cancer cell lines and mice models. Trop J Pharm Res 15:6 (2016), 1151–1157.
39. Yong, Y.L., Tan, L.T., Ming, L.C., Chan, K.G., Lee, L.H., Goh, B.H., et al. The effectiveness and safety of topical capsaicin in postherpetic neuralgia: a systematic review and meta-analysis. Front Pharm, 2017, 10.3389/fphar.2016.00538.
40. Srikanth, S., Chen, Z., Plant protease inhibitors in therapeutics-focus on cancer therapy. Front Pharma, 2016, 10.3389/fphar.2016.00470.
41. Pahari, P., Saikia, U.P., Das, T.P., Damodaran, C., Rohr, J., Synthesis of psoralidin derivatives and their anticancer activity: first synthesis of lespeflorin I 1. Tetrahedron 72:23 (2016), 3324–3334.
42. Amin, S., Barkatullah, H.K., Pharmacology of Xanthium species. A review. J Phytopharm 5 (2016), 126–127.
43. Thangapazham, R.L., Sharad, S., Maheshwari, R.K., Phytochemicals in wound healing. Adv Wound Care 5:5 (2016), 230–241.
44. Tu, L.Y., Pi, J., Jin, H., Cai, J.Y., Deng, S.P., Synthesis, characterization and anticancer activity of kaempferol-zinc (Ⅱ) complex. Bioorg Med Chem Lett 26:11 (2016), 2730–2734.
45. Lee, I.C., Choi, B.Y., WithaferinA-a natural anticancer agent with pleitropic mechanisms of action. Int J Mol Sci, 17(3), 2016, 290.
46. Wal, A., Srivastava, R.S., Wal, P., Rai, A., Sharma, S., Lupeol as a magic drug. Pharm Biol Eval 2 (2015), 142–151.
47. Rastogi, N., Duggal, S., Singh, S.K., Porwal, K., Srivastava, V.K., Maurya, R., et al. Proteosome inhibition mediates p53 reactivation and anticancer activity of 6-gingerol in cervical cancer cells. Oncotarget 6 (2015), 43310–43325.
48. Tsai, C.C., Chuang, T.W., Chen, L.J., Niu, H.S., Chung, K.M., Cheng, J.T., et al. Increase in apoptosis by combination of metformin with silibinin in human colorectal cancer cells. World J Gastroenterol 21 (2015), 4169–4177.
49. Osman, N.H.A., Said, U.Z., El-Waseef, A.M., Ahmed, E.S.A., Luteolin supplementation adjacent to aspirin treatment reduced dimethyl hydrazine-induced experimental colon carcinogenesis in rats. Tumour Biol 36 (2015), 1179–1190.
50. Lin, X., Peng, Z., Su, C., Potential anticancer activities and mechanisms of costunolide and dehydrocostuslactone. Int J Mol Sci 16 (2015), 10888–10906.
51. Mukhija, M., Singh, M.P., Dhar, K.L., Kalia, A.N., Cytotoxic and antioxidant activity of Zanthoxylum alatum stem bark and its flavonoid constituents. J Pharm Phytochem, 4, 2015, 86.
52. Garg, P., Deep, A., Anti-cancer potential of boswellic acid: a mini review. Hygeia J D Med 7:2 (2015), 18–27.
53. Ramasamy, K., Agarwal, R., Multitargeted therapy of cancer by silymarin. Cancer Lett 269:2 (2008), 352–362.
54. Vallianou, N.G., Evangelopoulos, A., Schizas, N., Kazazis, C., Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res 35 (2015), 645–651.
55. Monika, Singh J., Plants and phytochemicals as potential source of anticancer agents. Inte J Adv Res 4 (2015), 307–317.
56. Choi, J.Y., Hong, W.G., Cho, J.H., Kim, E.M., Kim, J., Jung, C.H., et al. Podophyllotoxin acetate triggers anticancer effects against non-small cell lung cancer cells by promoting cell death via cell cycle arrest, ER stress and autophagy. Inter J Oncol 47 (2015), 1257–1265.
57. Hoshyar, R., Mollaei, H., A comprehensive review on anticancer mechanisms of the main carotenoid of saffron, crocin. J Pharm Pharmacol 1 (2017), 1–9.
58. Liu, Y.Q., Tian, J., Qian, K., Zhao, X.B., Susan, L.M., Yang, L., Recent progress on c-4 modified Podophyllotoxin analogs as potent antitumor agents. Med Res Rev 35 (2015), 1–62.
59. Król, S.K., Kiełbus, M., Rivero-Müller, A., Stepulak, A., Comprehensive review on betulin as a potent anticancer agent. Bio Med Res Int, 2015, 2015, 584189, 10.1155/2015/584189.
60. Wang, C., Zhang, Z., Wan, Z., Zhang, J.Y., Anderson, C.F., He, X., et al. Protopanaxadiol, an active ginseng metabolite, significantly enhances the effects of fluorouracil on colon cancer. Nutrients 7 (2015), 799–814.
61. Lan, L., Appelman, C., Smith, A.R., Yu, J., Larsen, S., Marquez, R.T., et al. Natural product 1064 (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1. Mol Oncol 9 (2015), 1406–1420.
62. Leon, I.E., Cadavid-Vargas, J.F., Tiscornia, I., Porro, V., Castelli, S., Katkar, P., et al. Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model. J Biol Inorg Chem 20 (2015), 1175–1191.
63. Yan, C.H., Li, F., Ma, Y.C., Plumbagin shows anticancer activity in human osteosarcoma (MG-63) via the inhibition of s-phase checkpoints and downregulation of c-myc. Int J Clin Exp Med 8 (2015), 14432–14439.
64. Ghasemzadeh, A., Jaafar, H.Z.E., Rahmat, A., Optimization protocol for the extraction of 6-gingerol and 6-shogaol from Zingiber offcinale var. rubrum and improving antioxidant and anticancer activity using response surface methodology. BMC Complement Altern Med, 15, 2015, 258.
65. Perrone, D., Ardito, F., Giannatempo, G., Dioguardi, M., Troiano, G., Russo, L.L., et al. Biological and therapeutic activities and anticancer properties of curcumin. Exp Ther Med 10 (2015), 1615–1623.
66. Wozniak, L., Skapska, S., Marszalek, K., Ursolic acid-a pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules 20 (2015), 20614–20641.
67. Pang, S.Q., Wang, G.Q., Lin, J.S., Diao, Y., Xu, R.A., Cytotoxic activity of the alkaloids from Broussonetia papyrifera fruits. Pharm Biol 52 (2014), 1315–1319.
68. Jung, S.K., Lee, M.H., Kim, J.E., Singh, P., Lee, S.Y., Jeong, C.H., et al. Isoliquiritigenin induces apoptosis and inhibits xenograft tumor growth of human lung cancer cells by targeting both wild type and L858R/T790M mutant EGFR. J Bio Chem 289 (2014), 35839–35848.
69. Mishra, S., Aeri, V., Gaur, P.K., Jachak, S.M., Phytochemical, therapeutic, and ethnopharmacological overview for a traditionally important herb: Boerhavia diffusa Linn. BioMed Res Int, 2014, 2014, 808302, 10.1155/2014/808302.
70. Cheah, K.Y., Howarth, G.S., Bindon, K.A., Kennedy, J.A., Bastian, S.E., Low molecular weight procyanidins from grape seeds enhance the impact of 5-Fluorouracil chemotherapy on Caco-2 human colon cancer cells. PloS One, 9, 2014, e98921.
71. Ali, I., Braun, D.P., Resveratrol enhances mitomycin C-mediated suppression of human colorectal cancer cell proliferation by up-regulation of p21WAF1/CIP1. Anticancer Res 34 (2014), 5439–5446.
72. Aziz, A., Yusran, M., Omar, A.R., Subramani, T., Yeap, S.K., Ho, W.Y., et al. Damnacanthal is a potent inducer of apoptosis with anticancer activity by stimulating p53 and p21 genes in MCF-7 breast cancer cells. Oncol Lett 7 (2014), 1479–1484.
73. Guruvayoorappan, C., Kuttan, G., Immunomodulatory and antitumour activity of Biophytum senstivium extract. Asian Pac J Cancer Prev 8 (2007), 27–32.
74. Zhan, Y., Jia, G., Wu, D., Xu, Y., Xu, L., Design and synthesis of a gossypol derivative with improved antitumor activities. Arch Pharm Chem Life Sci 342 (2009), 223–229.
75. Shalabi, M., Khilo, K., Zakaria, M.M., Elsebaei, M.G., Abdo, W., Awadin, W., Anticancer activity of Aloe vera and Calligonum comosum extracts separately on hepatocellular carcinoma cells. Asian Pac J Trop Biomed 5:5 (2015), 375–381.
76. El-Shemy, H.A., Aboul-Soud, M.A., Nassr-Allah, A.A., Aboul-Enein, K.M., Kabash, A., Yagi, A., et al. Antitumor properties and modulation of antioxidant enzymes’ activity by Aloe vera leaf active principles isolated via supercritical carbon dioxide extraction. Curr Med Chem 17 (2010), 129–138.
77. Formagio, A.S.N., Vieira, M.C., Volobuff, C.R.F., Silva, M.S., Matos, A.I., Cardoso, C.A.L., et al. In vitro biological screening of the anticholinesterase and antiproliferative activities of medicinal plants belonging to Annonaceae. Braz J Med Bio Res 48 (2015), 308–315.
78. Leyva-Peralta, M.A., Robles-Zepeda, R.E., Garibay-Escobar, A., Ruiz-Bustos, E., Alvarez-Berber, L.P., Galvez-Ruiz, J.C., et al. In vitro anti-proliferative activity of Argemone gracilenta and identification of some active components. BMC Comp Alter Med, 15, 2015, 13.
79. Wang, Y., Hong, C., Zhou, C., Xu, D., Qu, H.B., Screening antitumor compounds psoralen and isopsoralen from Psoralea corylifolia L. seeds. EvidBased Comp Altern Med, 2011, 2011, 363052, 10.1093/ecam/nen087.
80. Khalafalla, M.M., Dafalla, H.M., Nassrallah, A., Aboul-Enein, K.M., El-Shemy, H.A., Abdellatef, E., et al. Dedifferentiation of leaf explants and antileukemia activity of an ethanolic extract of cell cultures of Moringa oleifera. Afric J Biotech 10 (2011), 2746–2750.
81. Chan, L.L., George, S., Ahmad, I., Gosangari, S.L., Abbasi, A., Cunningham, B.T., et al. Cytotoxicity effects of Amoora rohituka and chittagonga on breast and pancreatic cancer cells. Evid base Compl Altern Med, 2011, 2011, 860605, 10.1155/2011/860605.
82. Csupor-Loffler, B., Hajdu, Z., Zupkó I., Molnár, J., Forgo, P., Vasas, A., et al. Antiproliferative constituents of the roots of Conyza canadensis. Plant Med 77 (2011), 1183–1188.
83. Unnati, S., Ripal, S., Sanjeev, A., Niyat, A., Novel anticancer agents from plant sources. Chin J Nat Med 11 (2013), 16–23.
84. Du, G.J., Wang, C.Z., Qi, L.W., Zhang, Z.Y., Calway, T., He, T.C., et al. The synergistic apoptotic interaction of panaxadiol and epigallocatechin gallate in human colorectal cancer cells. Phytother Res 27 (2013), 272–277.
85. Keglevich, P., Hazai, L., Kalaus, G., Szantay, C., Modifications of basic skeleton of vinblastin and vincristine. Molecules 17 (2012), 5893–5914.
86. Heidari, M., Heidari-Vala, H., Sadeghi, M.R., Akhondi, M.M., The inductive effects of Centella asiatica on rat spermatogenic cell apoptosis in vivo. J Nat Med 66 (2012), 271–278.
87. Bhouri, W., Boubaker, J., Skandrani, I., Ghedira, K., Ghedira, L.C., Investigation of the apoptotic way induced by digallic acid in human lymphoblastoid TK6 cells. Cancer Cell Int, 12, 2012, 26.
88. Raihan, M.O., Tareq, S.M., Brishti, A., Alam, M.K., Haque, A., Al, M.S., et al. Evaluation of antitumor activity of Leea indica (Burm.f.) merr extract against Ehrlich ascites carcinoma (EAC) bearing mice. Am J Biomed Sci 4 (2012), 143–152.
89. 2/M arrest in HT-29 cells of dichloromethane fraction from Liriodendron tulipifera. J Med Plants Res 6 (2012), 424–432.
90. Magee, P.J., Owusu-Apenten, R., McCann, M.J., Gill, C.I., Rowland, I.R., Chickpea (Cicer arietinum) and other plant-derived protease inhibitor concentrates inhibit breast and prostate cancer cell proliferation in vitro. Nutr Cancer 64 (2012), 741–748.
91. Hoshyar, R., Mollaei, H., A comprehensive review on anticancer mechanisms of the main carotenoid of saffron, crocin. J Pharm Pharmacol, 2017, 10.1111/jphp.12776.
92. Arpita, R., Navneeta, B., Centella asiatica: a pharmaceutically important medicinal plant. Curr Trends Biomed Eng Biosci, 5(3), 2017, 555661.
93. Kaur, R., Karan, K., Kaur, K., Plants as a source of anticancer agents. J Nat Prod Plant Resour, 1, 2011 119–112.
94. Hu, M., Xu, L., Yin, L., Qi, Y., Li, H., Xu, Y., et al. Cytotoxicity of dioscin in human gastric carcinoma cells through death receptor and mitochondrial pathways. J Appl Toxicol 33 (2013), 712–722.
95. Motta, F.C.M., Santos, D.Y.A.C., Salatino, M.L.F., Almeida, J.M.D., Negri, G., Carvalho, J.E., et al. Constituents and antiproliferative activity of extracts from leaves of Croton macrobothrys. Rev Bras Farmacogn 21 (2011), 972–977.
96. Maneerat, W., Thain, S., Cheenpracha, S., Prawat, U., Laphookhieo, S., New amides from the seeds of Clausana lansium. J Med Plants Res 5 (2011), 2812–2815.
97. Lauritano, H., Andersen, J.H., Hansen, E., Albrigtsen, M., Escalera, L., Esposit, F., et al. Bioactivity screening of microalgae for antioxidant, anti-inflammatory, anticancer, anti-diabetes, and antibacterial activities. Front Mar Sci, 3, 2016, 68.
98. Hahm, E.R., Moura, M.B., Kelley, E.E., Van Houten, B., Shiva, S., Singh, S.V., Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS One, 6, 2011, e23354.
99. Checker, R., Sharma, D., Sandur, S.K., Subrahmanyam, G., Krishnan, S., Poduval, T.B., et al. Plumbagin inhibits proliferative and inflammatory responses of T cells independent of ROS generation but by modulating intracellular thiols. J Cell Biochem 110 (2010), 1082–1093.
100. Bakshi, H.A., Sam, S., Anna, F., Zeinab, R., Ahmad, S.G., Sharma, M., et al. Crocin from Kashmiri saffron (Crocus sativus) induces in vitro and in vivo xenograft growth inhibition of Dalton's lymphoma (DLA) in mice. Asian Pac J Cancer Prev 10 (2009), 887–890.
101. Einbond, L.S., Soffritti, M., Esposti, D.D., Park, T., Cruz, E., Su, T., et al. Actein activates stress-and statin-associated responses and is bioavailable in Sprague-Dawley rats. Fund Clin Pharmacol 23 (2009), 311–321.
102. Ogunwande, I.A., Walker, T.M., Bansal, A., Setzer, W.N., Essien, E.E., Essential oil constituents and biological activities of Peristrophe bicalyculata and Borreria verticillata. Nat Prod Commun 5 (2010), 1815–1828.
103. Appendino, G., Chianese, G., Taglialatela-Scalfati, O., Cannabinoids: occurrence and medicinal chemistry. Curr Med Chem 18 (2011), 1085–1099.
104. Colombo, V., Lupi, M., Falcetta, F., Forestieri, D., D'Incalci, M., Ubezio, P., et al. Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells. Canc Chemother Pharmacol 67 (2011), 369–379.
105. Nakahata, A.M., Mayer, B., Rie, C., de Paula, C.A., Karow, M., Neth, P., et al. The effects of a plant proteinase inhibitor from Enterolobium contortisiliquum on human tumor cell lines. Biol Chem 392 (2011), 327–336.
106. Sakarkar, D.M., Deshmukh, V.N., Ethnopharmacological review of traditional medicinal plants for anti-cancer activity. Int J Pharm Technol Res 3 (2011), 298–308.
107. Xu, L.N., Lu, B.N., Hu, M.M., Xu, Y.W., Han, X., Qi, Y., et al. Mechanisms involved in the cytotoxic effects of berberine on human colon cancer HCT-8 cells. Biocell 36 (2012), 113–120.
108. Karmakar, S., Roy Choudhury, S., Banik, N., Ray, S., Molecular mechanisms of anti-cancer action of garlic compounds in neuroblastoma. Anti Canc Agents Med Chem 11 (2011), 398–407.
109. Lam, S.K., Ng, T.B., Novel galactonic acid-binding hexameric lectin from Hibiscus mutabilis seeds with antiproliferative and potent HIV-1 reverse transcriptase inhibitory activities. Acta Biochim Pol, 56, 2009, 649.
110. Ververidis, F., Trantas, E., Douglas, C., Vollmer, G., Kretzschmar, G., Panopoulos, N., et al. Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part Ⅰ: chemical diversity, impacts on plant biology and human health. Biotechnol J 2 (2007), 1214–1234.
111. Lim do, Y., Park JH. Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin. Am J Physiol Gastrointest Liver Physiol 296 (2009), 1060–1068.
112. Madhuri, S., Pandey, G., Some anticancer medicinal plants of foreign origin. Curr Sci 96 (2009), 6–25.
113. Cragg, G.M., Newman, D.J., Plants as a source of anti-cancer agents. J Ethnopharmacol 100 (2005), 72–79.
114. Bao, M.F., Yan, J.M., Cheng, G.G., Li, X.Y., Liu, Y.P., Li, Y., et al. Cytotoxic indole alkaloids from Tabernaemontana divaricata. J Nat Prod 76 (2013), 1406–1412.
115. Sabnis, M., Chemistry and pharmacology of ayurvedic medicinal plants. 2006, Prakashan: Chaukhambha Amarabharati.
116. Rahman, S., Carter, P., Bhattarai, N., Aloe vera for tissue engineering applications. J Funct Biomater, 8(1), 2017, 6.
117. Agarwal, B.B., Kumar, A., Bharti, A.C., Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23 (2003), 363–398.
118. Merina, N., Chandra, K.J., Jibon, K., Medicinal plants with potential anticancer activities: a review. Int Res J Phar 3 (2012), 26–30.
119. Weng, J.R., Li, Y.B., Chiu, C.F., Hu, J.L., Chiu, S.J., Wu, C.Y., et al. Cucurbitane triterpenoid from Momordica charantia induces apoptosis and autophagy in breast cancer cells, in part, through peroxisome proliferator-activated receptor c activation. Evid Based Comp Altern Med, 2013, 2013, 935675, 10.1155/2013/935675.
120. Kaushik, R.P., Narayanan, V., Vasudevan, G., Muthukumaran, G., Antony, U., Nutrient composition of cultivated Stevia leaves and the influence of polyphenols and plant pigments on sensory and antioxidant properties of leaf extracts. J Food Sci Tech 47 (2010), 27–33.
121. Das, I., Das, S., Saha, T., Saffron suppresses oxidative stress in DMBA-induced skin carcinoma: a histopathological study. Acta Histochem 112 (2010), 317–327.
122. Yoon, J.S., Kim, H.M., Yadunandam, A.K., Kim, N.H., Jung, H.A., Choi, J.S., et al. Neferine isolated from Nelumbo nucifera enhances anti-cancer activities in Hep3B cells: molecular mechanisms of cell cycle arrest, ER stress induced apoptosis and anti-angiogenic response. Phytomed 15 (2013), 1013–1022.
123. Ng, T.B., Lam, Y.W., Wang, H., Calcaelin, a new protein with translation-inhibiting, antiproliferative and antimitogenic activities from the mosaic puffball mushroom Calvatia caelata. Planta Med 69 (2003), 212–217.
124. Ngai, P.H.K., Ng, T.B., A ribonuclease with antimicrobial, antimitogenic and antiproliferative activities from the edible mushroom Pleurotus sajor-caju. Peptides 25 (2004), 11–17.
125. Smith, J.E., Zong, A., Rowan, N.J., Medicinal mushrooms: their therapeutic properties and current medical usage with special emphasis on cancer treatments. 2002, Canc Res, London.
126. Srivastava, J.K., Gupta, S., Antiproliferative and apoptotic effects of chamomile extract in various human cancer cells. J Agric Food Chem 55 (2007), 9470–9478.
127. ALim, T.K., Edible medicinal and non-medicinal plants, vol. 5, 2013, Springer, Netherlands Fruits.
128. Suzuki, K., Yano, T., Sadzuka, Y., Sugiyama, T., Seki, T., Asano, R., Restoration of connexin 43 by Bowman-Birk protease inhibitor in M5067 bearing mice. Oncol Rep 13 (2005), 1247–1250.
129. Huang, G.J., Sheu, M.J., Chen, H.J., Chang, Y.S., Lin, Y.H., Growth inhibition and induction of apoptosis in NB4 promyelocytic leukemia cells by trypsin inhibitor from sweet potato storage roots. J Agr Food Chem 55 (2007), 2548–2553.
130. Rakashanda, S., Mubashir, S., Qureshi, Y., Hamid, A., Masood, A., Amin, S., et al. Trypsin inhibitors from Lavatera cashmeriana camb. seeds: isolation, characterization and in-vitro cytoxic activity. Int J Pharm Sci Invent 2 (2013), 55–65.
131. Caccialupi, P., Ceci, L.R., Siciliano, R.A., Pignone, D., Clemente, A., Sonnante, G., Bowman-birk inhibitors in lentil: heterologous expression, functional characterisation and anti-proliferative properties in human colon cancer cells. Food Chem 120 (2010), 1058–1066.
132. Lanza, A., Tava, A., Catalano, M., Ragona, L., Singuaroli, I., Robustelli della Cuna, F.S., et al. Effects of the Medicago scutellata trypsin inhibitor (MsTI) on cisplatin-induced cytotoxicity in human breast and cervical cancer cells. Anticancer Res 24 (2004), 227–234.
133. Sun, J., Wang, H., Ng, T.B., Trypsin isoinhibitors with antiproliferative activity toward leukemia cells from Phaseolus vulgaris cv ‘white cloud bean’. J Biomed Biotech, 2010, 2010, 219793.
134. Runchana, R., Wannee, J., Pea, Pisum sativum, and its anticancer activity. Pharmacog Rev 11:21 (2017), 39–42.
135. Satheesh, L.S., Murugan, K., Antimicrobial activity of protease inhibitor from leaves of Coccinia grandis (L.) Voigt. Ind J Exp Biol 49 (2011), 366–374.
136. Suzuki, R., Kohno, H., Sugie, S., Sasaki, K., Yoshimura, T., Wada, K., et al. Preventive effects of extract of leaves of ginkgo (Ginkgo biloba) and its component bilobalide on azoxymethane-induced colonic aberrant crypt foci in rats. Canc Lett 210 (2004), 159–169.
137. Seo, W.G., Hwang, J.C., Kang, S.K., Jin, U.H., Suh, S.J., Moon, S.K., et al. Suppressive effect of Zedoariae rhizoma on pulmonary metastasis of B16 melanoma cells. J Ethnopharmacol 101 (2005), 249–257.
138. Zhao, Y., Wang, C.M., Wang, B.G., Zhang, C.X., Study on the anticancer activities of the Clematis manshrica saponins in vivo. China J Chin Mater Med 30 (2005), 1452–1453.
139. Imai, M., Kikuchi, H., Denda, T., Ohyama, K., Hirobe, C., Toyoda, H., et al. Cytotoxic effects of flavonoids against a human colon cancer derived cell line, COLO 201: a potential natural anti-cancer substance. Canc Lett 276 (2009), 74–80.
140. Yadav, B., Bajaj, A., Saxena, M., Saxena, A.K., In vitro anticancer activity of the root, stem and leaves of Withania somnifera against various human cancer cell lines. Indian J Pharm Sci, 72, 2010, 659.
141. Benarba, B., Meddah, B., Ethnobotanical study, antifungal activity, phytochemical screening and total phenolic content of Algerian Aristolochia longa. J Intercult Ethnopharmacol, 3, 2014, 150.
142. Babykutty, S., Padikkala, J., Sathiadevan, P., Vijayakurup, V., Azis, T., Srinivas, P., et al. Apoptosis induction of Centella asiatica on human breast cancer cells. Afr J Tradit Complement Altern Med 25 (2009), 9–16.
143. Sahreen, S., Khan, M.R., Khan, R.A., Shah, N.A., Estimation of flavonoids, antimicrobial, antitumor and anticancer activity of Carissa opaca fruits. BMC Compl Alter Med, 13, 2013, 372.
144. Li, J., Li, Q.C., Chen, C., Hao, X., Liu, H., Cytotoxic activity of cardenolides and cardenolide glycosides from Asclepias curassavica. Biooorganic Med Chem Lett 19 (2009), 1956–1959.
145. Biba, V.S., Jeba, M.P.W., Remani, P., Differential effects of Annona squamosa seed extracts: antioxidant, antibacterial, cytotoxic and apoptotic study. Int J Pharm Biol Sci 4 (2013), 899–907.
146. Mahata, S., Maru, S., Shukla, S., Pandey, A., Mugesh, G., Das, B.C., et al. Anticancer property of Bryophyllum pinnata (Lam.) Oken. leaf on human cervical cancer cells. BMC Compl Alter Med, 12, 2012, 15.
147. Choedon, T., Shukla, S.K., Kumar, V., Chemopreventive and anticancer properties of the aqueous extract of flowers of Butea monosperma. J Ethnopharmacol 129 (2010), 208–213.
148. Awale, S., Linn, T.Z., Li, F., Identification of chrysoplenetin from Vitex negundo as a potential cytotoxic agent against PANC-1 and a panel of 39 human cancer cell lines (JFCR39). Phytother Res 25 (2011), 1770–1775.
149. Shaban, A., Mani, G.M., Nautiyal, R., In vitro cytotoxicity of Moringa oleifera against different human cancer cell lines. Asian J Pharma Clin Res 5 (2012), 271–272.
150. Afify, M.R.A., Fayed, A.S., Shalaby, E.A., El-Shemy, A.H., Syzygium cumini (pomposia) active principles exhibit potent anticancer and antioxidant activities. Afr J Pharm Pharmacol 5 (2011), 948–956.
151. Brahmachari, G., Gorai, D., Roy, R., Argemone mexicana: chemical and pharmacological aspects. Braz J Pharmacog 23 (2013), 559–575.
152. Hirata, T., Fujii, M., Akita, K., Identification and physiological evaluation of the components from Citrus fruits as potential drugs for anti-corpulence and anticancer. Bioorgan Med Chem 17 (2009), 25–28.
153. Reddy, K.P., Bid, H.K., Nayak, V.L., In-vitro and in-vivo anticancer activity of 2-deacetoxytaxinine J and synthesis of novel taxoids and their in vitro anticancer activity. Eur J Med Chem 44 (2009), 3947–3953.
154. aDe Bono, J.S., Oudard, S., Ozguroglu, M., Hansen, S., Machiels, J.P., Kocak, I., et al. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet 376 (2010), 1147–1154.
155. Atkinson, J.M., Falconer, R.A., Edwards, D.R., Pennington, C.J., Siller, C.S., Shnyder, S.D., et al. Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases. Canc Res 70 (2010), 6902–6912.
156. Dieras, V., Limentani, S., Romieu, G., Tubiana-Hulin, M., Lortholary, A., Kaufman, P., et al. Phase Ⅱ multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapy. Ann Oncol 19:7 (2008), 1255–1260.
157. Pierpaoli, E., Damiani, E., Orlando, F., Lucarini, G., Bartozzi, B., Lombardi, P., et al. Antiangiogenic and antitumor activities of berberine derivative NAX014 compound in a transgenic murine model of HER2/neu-positive mammary carcinoma. Carcinogenesis 36:10 (2015), 1169–1179.
158. Singh, S., Jarial, R., Kanwar, S.S., Therapeutic effect of herbal medicines on obesity: herbal pancreatic lipase inhibitors. Wudpecker J Med Plants 2 (2013), 53–65.
159. Maryam, M., Go, R., Yien, C.Y.S., Nazre, M., Vinca alkaloids. Int J Prev Med 4 (2013), 1231–1235.
160. Almagro, L., Fernández-Perez, F., Pedreno, M.A., Indole alkaloids from Catharanthus roseus: bioproduction and their effect on human health. Molecules 20 (2015), 2973–3000.
161. Xie, S., Zhou, J., Harnessing plant biodiversity for the discovery of novel anticancer drugs targeting microtubules. Front Plant Sci, 8, 2017, 720.
162. Schutz, F.A., Bellmunt, J., Rosenberg, J.E., Choueiri, T.K., Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid. Expert Opin Drug Saf 10 (2011), 645–653.
163. Darshan, M.S., Loftu, M.S., Thadani-Mulero, M., Levy, B.P., Escuin, D., Zhou, X.K., et al. Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer. Cancer Res 71 (2011), 6019–6029.
164. Ojima, I., Lichtenthal, B., Lee, S., Wang, C., Wang, X., Taxane anticancer agents: a patent perspective. Expert Opinon Ther Pat 26 (2016), 1–20.
165. Kim, S.H., Kaplan, J.A., Sun, Y., Shieh, A., Sun, H.L., Croce, C.M., et al. The self-assembly of anticancer camptothecin–dipeptide nanotubes: a minimalistic and high drug loading approach to increased efficacy. Chem-A Eurp J 21 (2015), 101–105.
166. Rahier, N.J., Thomas, C.J., Hecht, S.M., Camptothecin and its analogs. Cragg, G.M., Kingston, D.G.I., New, D.G., (eds.) Anticancer agents from natural products, 2005, Talylor and Francis, Boca Raton, FL, 5–22.
167. Heibliga, M., Sobha, M., Nicolini, F.E., Subcutaneous omacetaxine mepesuccinate in patients with chronic myeloid leukemia in tyrosine kinase inhibitor-resistant patients. Rev Pers 38 (2014), 1145–1153.
168. Feldman, E.J., Seiter, K.P., Ahmed, T., Baskind, P., Arlin, Z.A., Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia. Leukemia 10 (1996), 40–42.
169. Li, F.S., Weng, J.K., Demystifying traditional herbal medicine with modern approaches. Nat Plants 3:8 (2017), 1–7.
170. Negia, A.S., Gautama, Y., Alama, S., Chandaa, D., Luqmana, S., Sarkarb, J., et al. Natural antitubulin agents: Importance of 3,4,5-trimethoxyphenyl fragment. Bioorg Med Chem 23 (2015), 373–389.
171. Stiborova, M., Cerna, V., Moserova, M., Mrizova, I., Arlt, V.M., Frei, E., et al. The anticancer drug ellipticine activated with cytochrome P450 mediates DNA damage determining its pharmacological efficiencies: studies with rats, hepatic cytochrome P450 reductase null (HRN™) mice and pure enzymes. Int J Mol Sci 16 (2015), 284–306.
172. Kizek, R., Adam, V., Hrabeta, J., Eckschlager, T., Smutny, S., Burda, J.V., Anthracyclines and ellipticines as DNA-damaging anticancer drugs: recent advances. Phar Ther 133 (2012), 26–39.
173. Isah, T., Anticancer alkaloids from trees: development into drugs. Phcog Rev 10 (2016), 90–99.
174. Ohashi, M., Sugikawa, E., Nakanishi, N., Inhibition of p53 protein phosphorylation by 9-hydroxyellipticine: a possible anticancer mechanism. Jpn J Cancer Res 86 (1995), 819–829.
175. Mantena, S.K., Sharma, S.D., Katiyar, S.K., Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 5 (2006), 296–308.
176. Barzegar, E., Fouladdel, S.H., Movahhed, T.K., Atashpour, S.H., Ghahremani, H.M., Ostad, S.N., et al. Effects of berberine on proliferation, cell cycle distribution and apoptosis of human breast cancer T47D and MCF7 cell lines. Iran J Basic Med Sci 18 (2015), 334–342.
177. Xu, H., Zhang, S., Scutellarin induced apoptosis in HepG2 hepatocellular carcinoma cells via a STAT3 pathway. Phytother Res 27:10 (2013), 1524–1528.
178. Garon, E.B., Neidhart, J.D., Gabrail, N.Y., de Oliveira, M.R., Balkissoon, J., Kabbinavar, F., A randomized phase Ⅱ trial of the tumor vascular disrupting agent CA4P (fosbretabulintromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small-cell lung cancer. Onco Targets Ther, 9, 2016, 7275.
179. Prakash, O., Kumar, A., Kumar, P., Anticancer potential of plants and natural products: a review. Am J Pharmacol Sci 1 (2013), 104–115.
180. Venier, N.A., Yamamoto, T., Sugar, L.M., Adomat, H., Fleshner, N.E., Klotz, L.H., et al. Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model. Prostate 75:12 (2015), 1300–1311.
181. Clark, R., Lee, S.H., Anticancer properties of capsaicin against human cancer. Anticancer Res 36:3 (2016), 837–843.
182. Chang, H.C., Chen, S.T., Chien, S.Y., Kuo, S.J., Tsai, H.T., Chen, D.R., Capsaicin may induce breast cancer cell death through apoptosis-inducing factor involving mitochondrial dysfunction. Hum Exp Toxicol 30:10 (2011), 1657–1665.
183. Sarkar, A., Bhattacharjee, S., Mandal, D.P., Induction of apoptosis by eugenol and capsaicin in human gastric cancer AGS cells: elucidating the role of p53. Asian Pac J Cancer Prev 16:16 (2015), 6753–6759.
184. Kim, S., Moon, A., Capsaicin-lnduced apoptosis of h-ras-transformed human breast epithelial cells is rac-dependent via ros generation. Arch Pharm Res 27:8 (2004), 845–849.
185. Mallery, S.R., Zwick, J.C., Pei, P., Tong, M., Larsen, P.E., Shumway, B.S., et al. Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions. Cancer Res 68 (2008), 4945–4957.
186. Wang, L.S., Burke, C.A., Hasson, H., Kuo, C.T., Molmenti, C.L.S., Seguin, C., et al. A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis. Cancer Prev Res 7 (2014), 666–674.
187. Chen, J., Mu, Q., Li, X., Yin, X., Yu, M., Jin, J., et al. Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells. Oncotarget, 8(25), 2017, 40318.
188. Rathkopf, D., Dickson, M.A., Feldman, D.R., Carvajal, R.D., Shah, M.A., Wu, N., et al. Phase Ⅰ study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors. Clin Cancer Res 15 (2009), 7405–7411.
189. Morimoto, Y., Maskarinec, G., Park, S.Y., Ettienne, R., Matsuno, R.K., Long, C., et al. Dietary isoflavone intake is not statistically significantly associated with breast cancer risk in the multiethnic cohort. Br J Nutr 112 (2014), 976–983.
190. Tang, N.P., Zhou, B., Wang, B., Yu, R.B., Ma, J., Flavonoids intake and risk of lung cancer: a meta-analysis. Jpn J Clin Oncol 39 (2009), 352–359.
191. Woo, H.D., Kim, J., Dietary flavonoid intake and risk of stomach and colorectal cancer. World J Gastroenterol 19 (2013), 1011–1019.
192. Kim, J.E., Kwon, J.Y., Seo, S.K., Son, J.E., Jung, S.K., Min, S.Y., et al. Cyanidin suppresses ultraviolet B-induced COX-2 expression in epidermal cells by targeting MKK4, MEK1, and Raf-1. Biochem Pharmacol 79 (2010), 1473–1482.
193. Singh, B.N., Shankar, S., Srivastava, R.K., Green tea catechin, epigallocatechin-3- gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82 (2011), 1807–1821.
194. Luthra, P.M., Lal, N., Prospective of curcumin, a pleiotropic signaling molecule from Curcuma longa in the treatment of glioblastoma. Eur J Med Chem 109 (2016), 23–35.
195. Patel, S., Sarwat, M., Khan, T.H., Mechanism behind the anti-tumour potential of saffron (Crocus sativus L.): the molecular perspective. Crit Rev Oncol/Hematolo 115 (2017), 27–35.
196. Morris, J., Moseley, V.R., Cabang, A.B., Coleman, K., Wei, W., Garrett-Mayer, E., et al. Reduction in promotor methylation utilizing EGCG (Epigallocatechin-3-gallate) restores RXRalpha expression in human colon cancer cells. Oncotarget 7 (2016), 11–17.
197. Qiao, Y., Cao, J., Xie, L., Shi, X., Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells. Arch Pharm Res 32 (2009), 1309–1315.
198. Budisan, L., Gulei, D., Zanoaga, O.M., Irimie, A.I., Sergiu, C., Braicu, C., et al. Dietary Intervention by phytochemicals and their role in modulating coding and non-coding genes in cancer. Int J Mol Sci, 18(6), 2017, 1178.
199. Philips, B.J., Coyle, C.H., Morrisroe, S.N., Chancellor, M.B., Yoshimura, N., Induction of apoptosis in human bladder cancer cells by green tea catechins. Biomed Res 30 (2009), 207–215.
200. Park, Y.J., Wen, J., Bang, S., Park, S.W., Song, S.Y., [6]-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells. Yonsei Med J 47 (2006), 688–697.
201. Oyagbemi, A., Saba, A., Azeez, O., Capsaicin: a novel chemopreventive molecule and its underlying molecular mechanisms of action. Indian J Cancer 47 (2010), 53–58.
202. Bernard, M.M., McConnery, J.R., Hoskin, D.W., [10]-Gingerol, a major phenolic constituent of ginger root, induces cell cycle arrest and apoptosis in triple-negative breast cancer cells. Exp Mol Pathol 102:2 (2017), 370–376.
203. Nahum, A., Hirsch, K., Danilenko, M., Watts, C., Prall, O., Levy, J., et al. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27 (Kip1) in the cyclin E-cdk2 complexes. Oncogene 20 (2001), 3428–3436.
204. Carini, F., David, S., Tomasello, G., Mazzola, M., Damiani, P., Rappa, F., et al. Colorectal cancer: an update on the effects of lycopene on tumor progression and cell proliferation. JBRHA 31:3 (2017), 1–9.
205. Cha, J.H., Kim, W.K., Ha, A.W., Kim, M.H., Chang, M.J., Anti-inflammatory effect of lycopene in SW480 human colorectal cancer cells. Nutr Res Pract 11:2 (2017), 90–96.
206. Gorham, E.D., Garland, C.F., Garland, F.C., Grant, W.B., Mohr, S.B., Lipkin, M., Optimal vitamin D status for colorectal cancer prevention: a quantitative meta-analysis. Am J Prev Med 32 (2007), 210–216.
207. Buyru, N., Tezol, A., Yosunkaya-Fenerci, E., Dalay, N., Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med 35 (2003), 550–555.
208. Garland, C.F., Mohr, S.B., Gorham, E.D., Grant, W.B., Garland, F.C., Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. Am J Prev Med 31 (2006), 512–514.
209. Zong, A., Cao, H., Wang, F., Anticancer polysaccharides from natural resources: a review of recent research. Carbohydr Polym 90 (2012), 1395–1410.
210. Maehara, Y., Tsujitani, S., Saeki, H., Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN): review of development and future perspectives. Surg Today 42 (2012), 8–28.
211. Ivanova, T.S., Krupodorova, T.A., Barshteyn, V.Y., Artamonova, A.B., Shlyakhovenko, V.A., Anticancer substances of mushroom origin. Exp Oncol 36 (2014), 58–66.
212. Mikiashvili, N., Elisashvili, V., Worku, M., Purification and characterization of a lectin isolated from the submerged cultivated mycelium of grey polypore Cerrena unicolor (Bull.) Murrill (Aphyllophoromycetideae). Int J Med Mushr 11 (2009), 61–68.
213. Xu, W., Huang, J.J., Cheung, P.C., Extract of Pleurotus pulmonarius suppresses liver cancer development and progression through inhibition of VEGF-induced PI3K/AKT signaling pathway. PLoS One, 7, 2011, e34406.
214. Barbieri, A., Quagliariello, V., Del Vecchio, V., Falco, M., Luciano, A., Amruthraj, et al. Anticancer and anti-inflammatory properties of ganoderma lucidum extract effects on melanoma and triple-negative breast cancer treatment. Nutrients, 9(3), 2017, 210.
215. Awadasseid, A., Hou, J., Gamallat, Y., Xueqi, S., Eugene, K.D., Hago, A.M., et al. Purification, characterization, and antitumor activity of a novel glucan from the fruiting bodies of Coriolus versicolor. PLoS One, 12(2), 2017, e0171270.
216. Wada, S., Cancer preventive effects of vitamin E. Curr Pharm Biotechnol 13 (2012), 156–164.
217. Geraets, L., Haegens, A., Brauers, K., Haydock, J.A., Vernooy, J.H., Wouters, E.F., et al. Inhibition of LPS-induced pulmonary inflammation by specific flavonoids. Biochem Biophys Res Comm 382 (2009), 598–603.
218. Khan, N., Afaq, F., Khusro, F.H., Adhami, V.M., Suh, Y., Mukhtar, H., Dual inhibition of PI3K/AKT and mTOR signaling in human non-small cell lung cancer cells by a dietary flavonoid fisetin. Int J Canc, 130, 2012, 1695.
219. Min, K.J., Nam, J.O., Kwon, T.K., Fisetin induces apoptosis through p53-mediated up-regulation of DR5 expression in human renal carcinoma caki cells. Molecule, 22(8), 2017, 1285.
220. Patel, K.R., Brown, V.A., Jones, D.J., Britton, R.G., Hemingway, D., Miller, A.S., et al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Canc Res 70 (2010), 7392–7399.
221. Varoni, E.M., Faro, A.F.L., Sharifi-Rad, J., Iriti, M., Anticancer molecular mechanisms of resveratrol. Front Nutr, 3, 2016, 8.
222. Brakenhielm, E., Cao, R., Cao, Y., Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 15:10 (2001), 1798–1800.
223. Jaswanth, A., Vasanthi, H.R., Rajamanickam, G.V., Saraswathy, A., Tumoricidal effect of the red algae Acanthophora spicifera on Ehrlich's ascites carcinoma cellsutilization. Seaweed Res 26:1–2 (2004), 217–223.
224. Yuan, Y.V., Carrington, M.F., Walsh, N.A., Extracts from dulse (Palmaria palmata) are effective antioxidants and inhibitors of cell proliferation in vitro. Food Chem Toxicol 43 (2005), 1073–1081.
225. Nuhu, A.A., Spirulina (Arthrospira): an important source of nutritional and medicinal compounds. J Mar Biol, 2013, 2013, 325636, 10.1155/2013/325636.
226. Seo, H.S., Jo, J.K., Ku, J.M., Choi, H.S., Choi, Y.K., Induction of caspase dependent extrinsic apoptosis through inhibition of signal transducer and activator of transcription 3 (STAT3) signaling in HER2-overexpressing BT-474 breast cancer cells. Biosci Rep, 35, 2015, e00276.
227. Bauer, D., Redmon, N., Mazzio, E., Soliman, K.F., Apigenin inhibits TNFα/IL-1α-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells. PloS One, 12(4), 2017, e0175558.
228. Liu, J., Zhang, Y., Qu, J., Xu, L., Hou, K., Zhang, J., et al. β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis. BMC Cancer, 11, 2011, 183.
229. Jiang, Z., Jacob, J.A., Loganathachetti, D.S., Nainangu, P., Chen, B., β-elemene: mechanistic studies on cancer cell interaction and its chemosensitization effect. Front Pharmacol, 8, 2017, 105.
230. Jiang, S., Ling, C., Li, W., Jiang, H., Zhi, Q., Jiang, M., Molecular mechanisms of anti-cancer activities of β-elemene: targeting hallmarks of cancer. Anti-cancer agents in medicinal chemistry. Form Curr Med Chem AntiCancer Agent 16 (2016), 1426–1434.
231. Das, M., Manna, K., Chalcone scaffold in anticancer armamentarium: a molecular insight. J Toxicol, 2016, 2016, 7651047, 10.1155/2016/7651047.
232. Shoaib, M., Shah, I., Ali, N., Adhikari, A., Tahir, M.N., Shah, S.W.A., Sesquiterpene lactone! a promising antioxidant, anticancer and moderate antinociceptive agent from Artemisia macrocephala jacquem. BMC Compl Altern Med, 17(1), 2017, 27.
233. Mehmood, T., Maryam, A., Ghramh, H.A., Khan, M., Ma, T., Deoxyelephantopin and isodeoxyelephantopin as potential anticancer agents with effects on multiple signaling pathways. Molecules, 22(6), 2017, 1013.
234. Kasala, E.R., Bodduluru, L.N., Madana, R., Gogoi, R., Barua, C.C., Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives. Toxicol Lett 233 (2015), 214–225.
235. Renuka, M., Vijayakumar, N., Ramakrishnan, A., Chrysin, a flavonoid attenuates histological changes of hyperammonemic rats: a dose dependent study. Biomed Pharmacother 82 (2016), 345–354.
236. Ryu, S., Lim, W., Bazer, F.W., Song, G., Chrysin induces death of prostate cancer cells by inducing ROS and ER stress. J Cell Physiol 232:12 (2017), 3786–3797.
237. Xing, J., You, H., Dong, Y., Lu, J., Chen, S., Zhu, H., et al. Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces. Acta Pharmacol Sin 32 (2011), 655–663.
238. Gao, C., Zhou, Y., Jiang, Z., Zhao, Y., Zhang, D., Cong, X., et al. Cytotoxic and chemosensitization effects of Scutellarin from traditional Chinese herb Scutellaria altissima L. in human prostate cancer cells. Oncol Rep 38:3 (2017), 1491–1499.
239. Yang, N., Zhao, Y., Wang, Z., Liu, Y., Zhang, Y., Scutellarin suppresses growth and causes apoptosis of human colorectal cancer cells by regulating the p53 pathway. Mol Med Rep 15:2 (2017), 929–935.
240. Chen, Y.C., Yang, L.L., Lee, T.J.F., Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-κB activation. Biochem Pharmacol 59 (2004), 1445–1457.
241. Ha, J., Zhao, L., Zhao, Q., Yao, J., Zhu, B.B., Lu, N., et al. Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway. Biochem Cell Biol 90 (2012), 521–531.
242. Lee, H.S., Cho, H.J., Yu, R., Lee, K.W., Chun, H.S., Park, J.H.Y., Mechanisms underlying apoptosis-inducing effects of kaempferol in HT-29 human colon cancer cells. Int J Mol Sci 15 (2014), 2722–2737.
243. Gutiérrez-del-Río, I., Villar, C.J., Lombó F., Therapeutic uses of kaempferol: anticancer and anti-inflammatory activity. Garde-Cerdán, T., Gonzalo-Diago, A., (eds.) Kaempferol: Biosynthesis, food sources and therapeutic uses, 2016, Nova Science Publishers, New York.
244. Lee, G.A., Choi, K.C., Hwang, K.A., Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells. Environ Toxicol Pharmacol 49 (2017), 48–57.
245. Marin, L., Miguelez, E.M., Villar, C.J., Lombó F., Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. Biomed Res Int, 1120, 2015, 905215.
246. Mizushina, Y., Shiomi, K., Kuriyama, I., Takahashi, Y., Yoshida, H., Inhibitory effects of a major soy isoflavone, genistein, on human DNA topoisomeraseⅡ activity and cancer cell proliferation. Int J Oncol 43 (2013), 1117–1124.
247. Luo, Y., Wang, S.X., Zhou, Z.Q., Wang, Z., Zhang, Y.G., Zhang, Y., et al. Apoptotic effect of genistein on human colon cancer cells via inhibiting the nuclear factor-kappa B (NF- κB) pathway. Tumour Biol 35 (2014), 11483–11488.
248. Ganai, A.A., Farooqi, H., Bioactivity of genistein: a review of in vitro and in vivo studies. Biomed Pharmacothe 76 (2015), 30–38.
249. Lee, J.I., Hsu, B.H., Wu, D., Barrett, J.S., Separation and characterization of silybin, isosilybin, silydianin and silychristin in milk thistle extract by liquid chromatography electrospray tandem mass spectrometry. J Chromatogr A 1116 (2006), 57–68.
250. Thorn, C.F., Oshiro, C., Marsh, S., Hernandez-Boussard, T., McLeod, H., Klein, T.E., et al. Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics 21 (2011), 440–446.
251. Kim, S.H., Ryu, H.G., Lee, J., Shin, J., Harikishore, A., Jung, H.Y., et al. Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells. Sci Rep, 5, 2015, 14570.
252. Chen, X.J., Zhang, X.J., Shui, Y.M., Wan, J.B., Gao, J.L., Anticancer activities of protopanaxadiol-and protopanaxatriol-type ginsenosides and their metabolites. Evid Based Complement Altern Med 2016 (2016), 1–19.
253. Ahuja, A., Kim, J.H., Kim, J.H., Yi, Y.S., Cho, J.Y., Functional role of ginseng-derived compounds in cancer. J Ginseng Res 16 (2017), 1–7.
254. Gao, J.L., Lv, G.Y., He, B.C., Zhang, B.Q., Zhang, H., Wang, N., et al. Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways. Oncol Rep 30 (2013), 292–298.
255. Kim, S.M., Lee, S.Y., Yuk, D.Y., Moon, D.C., Choi, S.S., Kim, Y., et al. Inhibition of 1043 NF-κB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch Pharm Res 32 (2009), 755–765.
256. Liang, L.D., He, T., Du, T.W., Fan, Y.G., Chen, D.S., Wang, Y., Ginsenoside-Rg5 induces apoptosis and DNA damage in human cervical cancer cells. Mol Med Rep 11:2 (2015), 940–946.
257. Zhu, H., Ding, W.J., Wu, R., Weng, Q.J., Lou, J.S., Jin, R.J., et al. Synergistic anti-cancer activity by the combination of TRAIL/APO-2L and celastrol. Cancer Invest 28 (2010), 23–32.
258. Yu, X., Ruan, X., Zhang, J., Zhao, Q., Celastrol induces cell apoptosis and inhibits the expression of the AML1-ETO/C-KIT oncoprotein in t (8; 21) leukemia. Molecules, 21(5), 2016, 574.
259. Fan, X.X., Li, N., Wu, J.L., Zhou, Y.L., He, J.X., Liu, L., et al. Celastrol induces apoptosis in gefitinib-resistant non-small cell lung cancer cells via caspases-dependent pathways and Hsp90 client protein degradation. Molecules 19:3 (2014), 3508–3522.
260. Cascao, R., Fonseca, J.E., Moita, L.F., Celastrol: a spectrum of treatment opportunities in chronic diseases. Front Med, 4, 2017, 69.
261. Meng, X., Liang, H., Luo, L., Antitumor polysaccharides from mushrooms: a review on the structural characteristics, antitumor mechanisms and immunomodulating activities. Carbohydr Res 424 (2016), 30–41.
262. Schepetkin, I.A., Quinn, M.T., Botanical polysaccharides: macrophage immunomodulation and therapeutic potential. Int Immunopharmacol 6 (2006), 317–333.
263. Zhang, Y., Li, Q., Wang, J., Cheng, F., Huang, X., Cheng, Y., et al. Polysaccharide from Lentinus edodes combined with oxaliplatin possesses the synergy and attenuation effect in hepatocellular carcinoma. Cancer Lett 377 (2016), 117–125.
264. Chu, B.F., Lin, H.C., Huang, X.W., Huang, H.Y., Wu, C.P., Kao, M.C., et al. An ethanol extract of Poria cocos inhibits the proliferation of non-small cell lung cancer A549 cells via the mitochondria-mediated caspase activation pathway. J Funct Foods 23 (2016), 614–627.
265. Liu, G., Kuang, S., Wu, S., Jin, W., Sun, C., A novel polysaccharide from Sargassum integerrimum induces apoptosis in A549 cells and prevents angiogenesis in vitro and in vivo. Sci Rep, 6, 2016, 26722.
266. Sun, Q., Dong, M., Wang, Z., Wang, C., Sheng, D., Li, Z., et al. Selenium enriched polysaccharides from Pyracantha fortuneana (Se-PFPs) inhibit the growth and invasive potential of ovarian cancer cells through inhibiting beta catenins signaling. Oncotarget 7 (2016), 28369–28383.
267. Luo, B., Wang, J., Li, X., Lu, W., Yang, J., Hu, Y., et al. New mild and simple approach to isothiocyanates: a class of potent anticancer agents. Molecules, 22(6), 2017, 773.
268. Pereira, L.P., Silva, P., Duarte, M., Rodrigues, L., Duarte, C.M., Albuquerque, C., et al. Targeting colorectal cancer proliferation, stemness and metastatic potential using brassicaceae extracts enriched in isothiocyanates: a 3D cell model-based study. Nutrients, 9(4), 2017, 368.
269. 2/M arrest in cervical cancer cells through cyclinB1 downregulation and GADD45β/CDC2 association. Int J Mol Sci, 17(9), 2016, 1530.
270. Shindo, S., Hosokawa, Y., Hosokawa, I., Ozaki, K., Matsuo, T., Genipin inhibits MMP-1 and MMP-3 release from TNF-α-stimulated human periodontal ligament cells. Biochimie 107 (2014), 391–395.
271. Pons, D.G., Nadal-Serrano, M., Torrens-Mas, M., Valle, A., Oliver, J., Roca, P., UCP2 inhibition sensitizes breast cancer cells to therapeutic agents by increasing oxidative stress. Free Radic Biol Med 86 (2015), 67–77.
272. Liu, H.E., Chang, A.S.Y., Teng, C.M., Chen, C.C., Tsai, A.C., Yang, C.R., Potent anti-inflammatory effects of denbinobin mediated by dual inhibition of expression of inducible no synthase and cyclooxygenase 2. Shock 35:2 (2011), 191–197.
273. Peiro, G., Ortiz-Martinez, F., Gallardo, A., Perez-Balaguer, A., Sanchez-Paya, J., Ponce, J.J., et al. Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma. Br J Cancer, 111(4), 2014, 689.